TRANSCAT INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TRANSCAT INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	144	155	161	173	173	205	231	259	278	332
Cost of revenue	109	118	122	131	127	147	162	176	189	224
Gross profit	35	37.4	39.3	42.5	46.1	58.4	68.4	83.8	89.5	108
Selling and marketing	16.6	16.6	17	18	17.7	20.6	24.8	28.7	33.3	42.8
General and administrative	10.5	11.9	12.2	13.6	17.3	23.6	27.3	35.3	38.2	52.3
Operating expenses	27	28.4	29.1	31.6	35	44.3	52.1	64	71.6	95
Operating income	7.93	9.03	10.2	10.9	11.1	14.1	16.2	19.8	17.9	13.3
Interest expense						0.81	2.42	1.84	0.8	4.6
Interest income						0	0	0.81	0.83	0.02
Other non-operating income	-0.77	-1.08	-0.99	-1.12	-1.09	-0.95	-2.76	-1.34	0.45	-5.27
Pre-tax income	7.16	7.95	9.24	9.73	9.98	13.2	13.5	18.4	18.3	7.99
Income tax	2.64	2.03	2.09	1.66	2.19	1.81	2.8	4.79	3.81	2.61
Net income	4.52	5.92	7.15	8.07	7.79	11.4	10.7	13.6	14.5	5.38
EBITDA	14.1	15	16.6	17.5	18.7	23.7	27.2	33.3	36.4	39.4
EPS, basic	0.65	0.83	0.99	1.10	1.05	1.52	1.42	1.66	1.58	0.58
EPS, diluted	0.64	0.81	0.95	1.08	1.03	1.50	1.40	1.63	1.57	0.57
Shares, basic (weighted)	6.99	7.12	7.2	7.33	7.42	7.5	7.55	8.24	9.19	9.33
Shares, diluted (weighted)	7.11	7.3	7.52	7.49	7.55	7.59	7.65	8.35	9.25	9.38

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	0.84	0.58	0.79	0.5	0.56	1.4	1.53	19.6	1.52	4.94
Short-term investments							0	15.5	0
Receivables	22	24.7	27.5	31	34	39.7	44.7	47.8	55.9	65.2
Inventory	10.3	12.7	14.3	14.2	11.6	12.7	16.9	17.4	14.5	13.7
Other current assets	1.19	1.24	1.33	1.7	2.35	5.3	3.94	4.28	5.7	7.97
Total current assets	35.6	40.5	45	48.5	48.9	59.7	67.6	105	78	92.5
Property, plant and equipment	15.6	17.1	19.7	20.8	22.2	26.4	29.1	38.9	50	57.8
Lease right-of-use assets				8.59	9.39	11	14.9	16.8	24.3	32.4
Goodwill	32.5	32.7	34.5	41.5	43.3	65.1	69.4	106	177	218
Intangible assets	7.52	5.51	5.23	7.98	7.51	14.7	13.8	20	54.8	77.7
Other non-current assets	0.9	0.97	0.79	0.72	0.81	0.83	1.05	1.06	1.16	1.97
Total assets	92.1	96.8	105	128	132	178	196	288	385	480
Accounts payable	11.6	13.5	14.6	11.9	12.3	14.2	15.9	11.5	16.8	17.9
Accrued liabilities	5.91	5.24	5.45	6.91	10.4	11.4	3.24	5.51	5.59	5.94
Short-term debt	1.43	2.14	1.9	1.98	2.07	2.16	2.25	2.34	1.82	0
Total current liabilities	19.8	21.2	22.1	20.9	25.1	27.7	28.3	33.5	34	39.6
Long-term debt	25.9	20.7	19.1	28.4	17.5	46.3	46.9	1.82	30.9	99.9
Lease liabilities				6.83	7.96	9.19	13	14.9	21.4	29
Other non-current liabilities	1.92	1.91	1.9	1.89	3.24	1.67	1.43	2.9	2.75	1.19
Total liabilities	48.7	45.5	45.6	61	57	91.6	96.1	62.4	98.4	180
Total debt	27.3	22.9	21	30.3	19.6	48.5	49.1	4.16	32.7	99.9
Paid-in capital	13	15	16.5	17.9	19.3	23.9	27.9	142	191	199
Retained earnings	27.3	33.1	40.2	46.5	52.5	58.7	69.2	80.1	92.5	97.8
Other comprehensive income	-0.41	-0.28	-0.61	-1.01	-0.45	-0.23	-1.2	-0.95	-1.47	-0.92
Shareholders' equity	43.4	51.3	59.6	67.1	75.1	86.2	99.6	225	287	301
Total equity	43.4	51.3	59.6	67.1	75.1	86.2	99.6	225	287	301
Total liabilities and equity	92.1	96.8	105	128	132	178	196	288	385	480
Shares outstanding	7.04	7.16	7.21	7.38	7.46	7.53	7.56	8.84	9.32	9.33

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	4.52	5.92	7.15	8.07	7.79	11.4	10.7	13.6	14.5	5.38
Depreciation and amortization	6.18	5.99	6.36	6.66	7.58	9.57	11	13.5	18.6	26.2
Stock-based compensation	0.45	1.41	1.33	0.88	1.51	2.33	3.38	4.51	3.25	7.55
Deferred income tax	0.07	0.53	0.78	0.42	0.21	0.4	-0.19	-1.56	0.02	0.83
Change in inventory	-3.43	-1.67	-1.1	0.88	2.72	-0.12	-3.38	2.32	4.39	0.84
Change in payables	3.11	1.92	0.96	-2.77	0.33	1.9	1.6	-5.01	4.94	0.97
Cash from operations	7.54	9.87	12.6	11.6	23.6	17.6	17	32.6	39	34.9
Capital expenditures	-5.25	-5.88	-7	-6.58	-6.62	-10.2	-9.41	-13.3	-13.2	-15.3
Acquisitions	-6.98		-3.61	-13	-3.55	-29.8	-9.11	-12.9	-87.4	-82.5
Purchases of investments						0	0	-15.5
Cash from investing	-12.2	-5.87	-10.9	-20.2	-10.2	-39.9	-18.5	-41.7	-84	-97.8
Debt issued	10	7.14	2.5
Debt repaid	-1.31	-1.73	-2.09	-1.9	-1.98	-2.11	-2.12	-2.25	-2.34
Stock issued	0.64	0.93	0.29	1.73	1.18	1.49	0.66	1.5	1.3	0.1
Share buybacks	-0.1	-0.36	-0.15	-2.82	-3.05	-6.68	-0.45	-4.91	-3.57	-0.47
Cash from financing	4.77	-3.98	-1.71	8.25	-12.7	23.7	0.88	27.4	26.9	66.5
Exchange rate effect	0.06	-0.29	0.26	0.15	-0.77	-0.63
Net change in cash	0.2	-0.27	0.21	-0.29	0.06	0.84	0.14	18.1	-18.1	3.43
Free cash flow	2.29	3.99	5.56	4.98	17	7.47	7.54	19.3	25.8	19.6
Interest paid	0.69	1.02	0.91	0.94	0.86	0.78	2.26	1.24
Income taxes paid	1.84	2.07	1.3	1.37	1.76	3.9	1.12	3.1	7.84	2.22

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $87.73 on September 25, 2026.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	19.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	12.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	13.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	21.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	16.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	18.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-25.8%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-6.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	3.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	8.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	13.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	16.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-63.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-20.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-7.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-63.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-25.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-11.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-10.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	27.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	8.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-24.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	37.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	2.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	4.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	44.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	32.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	24.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	34.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	29.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	7.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.49x	Current assets / current liabilities.
Quick ratio	1.91x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.17x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.36x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	22.4%	Total debt / total assets.
Liabilities / assets	38.5%	Total liabilities / total assets.
Net debt	$103.7M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$57.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	61.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.69x	Revenue / average total assets.
Fixed asset turnover	5.85x	Revenue / average property, plant and equipment.
Receivables turnover	5.11x	Revenue / average receivables.
Days sales outstanding	71 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
Revenue per share	$36.03	Revenue / diluted weighted shares.
Book value per share	$32.36	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.22	Tangible book value / shares outstanding.
Cash per share	$0.72	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$821.1M	Share price x shares outstanding.
Enterprise value	$924.8M	Market cap + total debt - cash - short-term investments.
P/S	2.41x	Market cap / revenue.
P/B	2.71x	Market cap / shareholders' equity. Only when equity is positive.
EV/Sales	2.71x	Enterprise value / revenue.

What was TRANSCAT INC's revenue in fiscal 2026?

TRANSCAT INC reported revenue of $331.9M for fiscal 2026, 19.2% higher than the year before.

Was TRANSCAT INC profitable in fiscal 2026?

Yes. Net income was $5.4M, a net margin of 1.6%.

How much free cash flow did TRANSCAT INC generate in fiscal 2026?

Cash from operations of $34.9M minus capital expenditures of $15.3M left free cash flow of $19.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TRANSCAT INC